SpeedWeed

JULY 28, 2021

The rise in calls can be attributed to a number of factors, from the market’s lack of standards to delta-8’s accessibility to minors. Other packaged and ready-made goods go through many good manufacturing practices (GMPs) and Food and Drug Administration (FDA) guidelines before they get to the shelf.

Research and Development 52

Research and Development Packaging Hemp Cannabinoids 52

MMJ Recs

MARCH 20, 2024

Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Medicinal Genomics

JANUARY 10, 2024

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. Look no further than the CannMed Advisory Board for evidence that the most esteemed clinicians and researchers make the trip to CannMed each year.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

JULY 13, 2021

LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. LEP) of Henderson, Nevada. from 2021 to 2028. For more information, visit www.eviolabs.com.

Research and Development 105

Research and Development Topical Cannabinoids Therapy 105

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. Full Job Description.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

AUGUST 30, 2021

KINGSTON, Jamaica–(BUSINESS WIRE)– #DOBUSINESSJAMAICA –Jamaica’s manufacturing sector has shown resilience through the COVID-19 pandemic, with the country seeing positive developments in industries such as chemicals and cosmetics. These developments support the island’s goal to be a manufacturing leader in the region.

Research and Development 105

Research and Development Supply Chain Packaging Food 105

Cannabis Law Report

OCTOBER 7, 2021

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the medical cannabis industry, this Directory will save you time and effort in finding the up to date information you need. Save the time, money and effort of doing your own research. Make vital contacts.

Research and Development 52

Research and Development Packaging Business Cannabis 52

Cannabis Law Report

DECEMBER 9, 2021

We believe this listing will enable Valens and its shareholders greater access to liquidity, increased corporate visibility, and a broader shareholder base, in an effort to create long-term shareholder value.”. Listing on Nasdaq is the next step to our capital markets strategy.

Research and Development 52

Research and Development Packaging Access Recreational 52

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

FEBRUARY 5, 2022

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Support new product development and further clinical activities.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Support new product development and further clinical activities.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

OCTOBER 26, 2021

We’re proud to be building this unrivaled global platform and will continue to advocate for patient access in Europe and countries around the world.”. We are committed to being a trusted partner, and we will continue to leverage our strong medical platform to increase access to the highest-quality medical cannabis for patients worldwide.”.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

OCTOBER 2, 2021

MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. Full Job Description.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

AUGUST 4, 2022

03, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that Fresh Hemp Foods, Ltd., NEW YORK, Aug.

CBD 52

CBD Research and Development Packaging Food 52

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

Cannabis Law Report

JANUARY 21, 2020

The proposal will administer social equity licensing opportunities, develop an egalitarian adult-use market structure and facilitate market entry through access to capital, technical assistance and incubation of equity entrepreneurs.

Research and Development 59

Research and Development Packaging Education Hemp 59

Cannabis Law Report

JANUARY 10, 2020

His proposal includes forming an Office of Cannabis Management to regulate medical, adult-use and hemp programs; ensuring that social equity and social justice needs are met; working in concert with neighboring states; and creating a cannabis and hemp research center at the State University of New York.

Research and Development 82

Research and Development Hemp Programs Packaging 82

Cannabis Law Report

DECEMBER 18, 2019

Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions. MGC was recently awarded a $25,000 payment from the Innovation Connection Grant from the Australian Government to support its research. Source: [link].

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

JANUARY 14, 2022

or more milligrams per serving or two or more milligrams total in the packaged product of any cannabinoid that may be impairing. milligrams per serving or two milligrams total in the packaged product of a cannabinoid that may be impairing. Conduct research. Limit youth access and youth exposure to cannabis.

Research and Development 52

Research and Development Cannabinoids Packaging Hemp 52

Cannabis Law Report

JUNE 28, 2021

Besides that, prompt adoption of new and latest methods amidst the pandemic made it an even more accessible and popular product across the country. . By this, they meant what they think about selling, labeling, and researching cannabis. Health Canada started an initiative to know what consumers feel about cannabis. Wrapping up.

Supply Chain 111

Supply Chain Research and Development Packaging Cannabis 111

Cannabis Law Report

MAY 22, 2022

A production licence would allow for all forms of commercial cultivation, importing seeds, research and analytical testing, as well as processing, packaging and labelling of commercial cannabis products. Age of access. Commercial producers would have production limits. Commercial producers would have production limits.

Seed-To-Sale 52

Seed-To-Sale Legalization Research and Development Legislation 52

SpeedWeed

MARCH 14, 2021

Many companies have been aggregating data from the cannabis market for research and analysis. Big Data Streamlines the Cannabis Regulatory Process and Helps Close the Scientific Research Gap. This data enables the businesses to develop better products and increase the return on their marketing investments. Improve efficiencies.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

JULY 14, 2021

The Cannabis Advisory Commission will become an important contributor in further developing cannabis regulation in Nevada,” CAC Chair and CCB Executive Director Tyler Klimas said. A’Esha Goins, Chair. Attorney General Aaron D. Senator Dallas Harris (D – 11 th District). Kema Ogden. Tina Ulman, Chamber of Cannabis. .

Compliance 102

Compliance Compliance Research and Development Safety 102

Cannabis Law Report

OCTOBER 14, 2021

As the medical market continues to grow and as legislators develop plans for adult-use, we are increasing our depth in the key state of Pennsylvania to strengthen our wholesale leadership while growing profitability and scale through new retail. Academic clinical research partnership with Lewis Katz School of Medicine at Temple University.

Research and Development 52

Research and Development Dispensary Seed-To-Sale Cultivation 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. Full Job Description. Holiday Pay.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

The Herb Collective

APRIL 2, 2023

By visiting a shop and speaking with knowledgeable staff, customers can get access to even more information about the kinds of cannabis that would be right for them, giving them confidence that they're making well-informed decisions. When you purchase from a weed shop, you are directly supporting the family that owns and operates it.

Strains 52

Strains Edibles Concentrates Education 52

Cannabis Law Report

JULY 28, 2021

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

SEPTEMBER 21, 2021

According to the research study, more than 90% of Americans eat ice cream. Packaging innovations also contribute to the increased demand for take-home products, as these new packs are more accessible to transport and store than older ones. Packaging – Market breakup from 6 viewpoints. Convenience Store.

Supply Chain 52

Supply Chain Research and Development Packaging Consumption 52

Cannabis Law Report

AUGUST 14, 2019

Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. One of the biggest challenges in the medical marijuana market is the inability to conduct clinical research on the efficacy of marijuana because it’s still a Schedule 1 drug at the federal level. Source: [link].

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

JUNE 9, 2021

“Wild By Nature’s agreement with Circle K creates a significant amount of momentum for our CBD products because it makes them more accessible to our target shopper who seeks both the wellness benefits of CBD and convenience,” said Wild President Jeremy Creighton.

CBD 66

CBD Research and Development Packaging Retail 66

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

Some researchers believe that cannabis can increase both creativity and productivity. [1] In fact, many successful people credit marijuana with helping them develop the very traits, habits, creativity, and skills that led to their success. In short, it is a difficult claim to find direct research to support. 1] Malceva, M.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Canna Law Blog

DECEMBER 30, 2021

A grand total of 1 licensed researcher exists— we work with them and it’s a funny story. Rather than rehash what happened in the 2021 session, and in the interests of space, I want to focus on a few key developments. The second noteworthy development stemming from HB 3000 has been OLCC administrative rulemaking. OLCC Rulemaking.

Hemp 83

Hemp Research and Development eCommerce Retail 83

Cannabis Law Report

MARCH 17, 2022

Cannabis strains are accessible in different formulations. Still, various reliable researches suggest that these commodities may be limited and beneficial. Package Date. Plus, weed grains rapidly assimilate in the soil farmed and developed. Finding Right Blend Of CBD. Evaluate The Product’s Label. Cannabinoid Content.

CBD 52

CBD Extraction Cannabinoids Strains 52

SpeedWeed

JULY 20, 2021

With aquaponics] we see increases in yields, increases in cannabinoids, and increases in terpenes,” said Danielle Maitland, aquaponics development supervisor at Aqualitas. I like to call them pets with jobs,” explained Danielle Maitland, Aqualitas’ aquaponics development supervisor. Women, weed, and animal welfare. Aqualitas). “I

Pets 52

Pets Packaging Cultivation Research and Development 52

Cannabis Law Report

OCTOBER 14, 2021

As the medical market continues to grow and as legislators develop plans for adult-use, we are increasing our depth in the key state of Pennsylvania to strengthen our wholesale leadership while growing profitability and scale through new retail. Academic clinical research partnership with Lewis Katz School of Medicine at Temple University.

Research and Development 52

Research and Development Dispensary Seed-To-Sale Cultivation 52